Management and safety of somatostatin receptor ligands and pegvisomant in pregnant women with acromegaly: a narrative review of the literature

Margherita Medici, Valentino Marino Picciola, Irene Comune, Alessandro Cicale, Maria Chiara Zatelli, Maria Rosaria Ambrosio

Open source

DOI
10.1007/s12020-026-04761-x
Published
2026-08-21
Container
Endocrine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12020-026-04761-x,
  title = {Management and safety of somatostatin receptor ligands and pegvisomant in pregnant women with acromegaly: a narrative review of the literature},
  author = {Margherita Medici and Valentino Marino Picciola and Irene Comune and Alessandro Cicale and Maria Chiara Zatelli and Maria Rosaria Ambrosio},
  year = {2026},
  journal = {Endocrine},
  doi = {10.1007/s12020-026-04761-x},
  url = {https://doi.org/10.1007/s12020-026-04761-x}
}

RIS

TY  - JOUR
TI  - Management and safety of somatostatin receptor ligands and pegvisomant in pregnant women with acromegaly: a narrative review of the literature
AU  - Margherita Medici
AU  - Valentino Marino Picciola
AU  - Irene Comune
AU  - Alessandro Cicale
AU  - Maria Chiara Zatelli
AU  - Maria Rosaria Ambrosio
PY  - 2026
JO  - Endocrine
DO  - 10.1007/s12020-026-04761-x
UR  - https://doi.org/10.1007/s12020-026-04761-x
ER  - 

APA

Medici, M., Picciola, V. M., Comune, I., Cicale, A., Zatelli, M. C., & Ambrosio, M. R. (2026). Management and safety of somatostatin receptor ligands and pegvisomant in pregnant women with acromegaly: a narrative review of the literature. Endocrine. https://doi.org/10.1007/s12020-026-04761-x

Source records